Hope Rugo, Md: Advances And Challenges In The Treatment Of Metastatic Breast Cancer

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer

Vital Options International

Dr. Rugo on Guidelines for the Treatment of Metastatic Breast Cancer

Targeted Oncology

Dr Rugo on Elacestrant-Based Combinations in ER+/HER2– Metastatic Breast Cancer

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer Management

Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatments

Karger Publishers

Dr. Rugo on Chemotherapy for Metastatic Breast Cancer

Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advanced Breast Cancer

Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast Cancer

Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer

New Directions in the Treatment of Breast Cancer: Bringing Biology to the Clinic and Back

UCSF Department of Medicine

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast Cancer

Targeted Oncology

Dr. Rugo on Pathway Blockade in Breast Cancer

Dr. Rugo on Unmet Needs Beyond Second-Line Treatment in HER2+ Breast Cancer

“Key Breakthroughs in the Field of Breast Cancer Treatment” by Dr. Hope Rugo

UCSF at #AACR24: Hope Rugo, MD | Clinical Trials Discussant on "Advanced in Targeted Therapy"

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Total Health | Oncology

Hope Rugo, MD: Chemotherapy Agents and Breast Cancer Treatment

Vital Options International

Dr. Rugo on 20-Year Span of Breast Cancer Advancements

Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General Session

San Antonio Breast Cancer Symposium

TROPiCS-02 shows sacituzumab govitecan OS benefit in HR+, HER2– advanced breast cancer | Hope Rugo

Medicine Matters oncology